
Acorda Therapeutics
A publicly traded biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.
Enterprise value
$185m
Share price
$0.26 ACOR
Recent deals
Authorizing premium user...